0001144204-13-049226.txt : 20130904 0001144204-13-049226.hdr.sgml : 20130904 20130904163030 ACCESSION NUMBER: 0001144204-13-049226 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130830 FILED AS OF DATE: 20130904 DATE AS OF CHANGE: 20130904 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DERMA SCIENCES, INC. CENTRAL INDEX KEY: 0000892160 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 232328753 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6095144744 MAIL ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DERMA SCIENCES INC DATE OF NAME CHANGE: 19940513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YETTER JOHN E CENTRAL INDEX KEY: 0001240335 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13070 FILM NUMBER: 131078226 MAIL ADDRESS: STREET 1: DERMA SCIENCES INC STREET 2: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 v354363_4.xml OWNERSHIP DOCUMENT X0306 4 2013-08-30 0 0000892160 DERMA SCIENCES, INC. DSCI 0001240335 YETTER JOHN E DERMA SCIENCES INC 214 CARNEGIE CENTER, SUITE 300 PRINCETON NJ 08540 0 1 0 0 EVP, Finance & CFO Common Stock 2013-08-30 4 S 0 500 14.01 D 58384 D Common Stock 2013-09-03 4 S 0 11600 14.17 D 46784 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan. Represents the weighted average sale price of multiple transactions with a range of prices between $14.00 to $14.05. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average sale price of multiple transactions with a range of prices between $14.00 to $14.30. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. /s/ John E. Yetter 2013-09-04